Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia

Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are recommended for secondary prevention in peripheral artery disease, but their effectiveness in patients with critical limb ischemia (CLI) is uncertain. We reviewed 464 patients with CLI who underwent diagnost...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Vascular medicine (London, England) Ročník 20; číslo 3; s. 237 - 244
Hlavní autori:	Armstrong, Ehrin J, Chen, Debbie C, Singh, Gagan D, Amsterdam, Ezra A, Laird, John R
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London, England SAGE Publications 01.06.2015 Sage Publications Ltd
Predmet:	Aged Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Critical Illness Female Follow-Up Studies Humans Ischemia - complications Leg - blood supply Male Proto-Oncogene Proteins Receptors, G-Protein-Coupled Retrospective Studies Time Factors peripheral artery disease critical limb ischemia guideline therapies adherence angiotensin converting enzyme inhibitor angiotensin receptor blocker prevention
ISSN:	1358-863X, 1477-0377
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!